SKI Market

A+| A| A-|

Indian Indices

Sensex

74,106.85 787.30
( 1.07%)

Global Indices

Nasdaq

46,689.37 163.69
(0.35%)

Dow Jones

6,632.05 28.36
(0.43%)

Hang Seng

53,576.26 452.77
(0.85%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.02 -0.15
(-0.16%)

EUR-INR

107.32 -0.65
(-0.60%)

GBP-INR

123.03 -0.78
(-0.63%)

JPY-INR

0.58 0.00
(-0.67%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

IOL Chemicals & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524164

INE485C01029

59.6576281

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IOLCP

18.7

2327.67

EPS(TTM)

Face Value()

Div & Yield %

4.24

1.01

Back

tilak finance ltd

Inventure Growth & Securities consolidated net profit rises 30700.00% in the December 2025 quarter

Feb 12,2026

Net profit of Inventure Growth & Securities rose 30700.00% to Rs 3.08 crore in the quarter ended December 2025 as against Rs 0.01 crore during the previous quarter ended December 2024. Sales rose 15.92% to Rs 12.16 crore in the quarter ended December 2025 as against Rs 10.49 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	12.16	10.49	16
OPM %	43.01	15.82	-
PBDT	4.24	0.77	451
PBT	3.99	0.61	554
NP	3.08	0.01	30700

74,106.85 787.30 ( 1.07%)

46,689.37 163.69 (0.35%)

6,632.05 28.36 (0.43%)

53,576.26 452.77 (0.85%)

10,436.29 71.50 (0.69%)

93.02 -0.15 (-0.16%)

107.32 -0.65 (-0.60%)

123.03 -0.78 (-0.63%)

0.58 0.00 (-0.67%)